|
Market Closed -
Saudi Arabian S.E.
15:20:00 15/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 65.40 SAR | -2.39% |
|
-2.53% | +2.92% |
| 08-27 | Avalon Pharma Reiterated at Overweight as Aljazira Capital Notes 'Solid' Q2 Growth | MT |
| 08-20 | Avalon Pharma Renews SAR50 Million Credit Facility | MT |
Stock exchange
Saudi Arabian S.E.
4016 65.40 ﷼
-2.39%
2.33M
﷼
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| 4016 | 65.40SAR | -2.39% | 2.33M ﷼ |
Quotes 5-day view: Middle East Pharmaceutical Industries Company
Delayed Quote Saudi Arabian S.E.
| 09/09/2026 | 10/09/2026 | 13/09/2026 | 14/09/2026 | 15/09/2026 | |
|---|---|---|---|---|---|
| Last | SAR 67.05 | SAR 66.60 | SAR 65.30 | SAR 67.00 | SAR 65.40 |
| Volume | 24,162 | 54,517 | 86,966 | 52,967 | 35,559 |
| Change | -0.07% | -0.67% | -1.95% | +2.60% | -2.39% |
| Opening | SAR 66.90 | SAR 67.05 | SAR 66.00 | SAR 65.25 | SAR 66.50 |
| High | SAR 67.45 | SAR 67.25 | SAR 66.25 | SAR 67.10 | SAR 66.50 |
| Low | SAR 66.85 | SAR 66.50 | SAR 64.80 | SAR 65.25 | SAR 65.00 |
Performance
| 1 day | -2.39% | ||
| 1 week | -2.53% | ||
| Current month | -3.82% | ||
| 1 month | +8.10% | ||
| 3 months | +5.31% | ||
| 6 months | +17.02% | ||
| Current year | +2.92% | ||
| 1 year | -4.70% |
Volumes
marketsDaily volume
35,559
Estimated daily volume
35,559
Avg. Volume 20 sessions
133,194
Daily volume ratio
0.27
Avg. Volume 20 sessions SAR
8,710,887.6
Avg. Volume 20 sessions USD
2,319,195.43
Record volume 1
7,299,233
Record volume 2
4,505,032
Record volume 3
3,303,143
Capital turnover ratio
0
Float rotation
0.01
Basic data
Market Cap (SAR)
2,345,249,740
Market Cap (USD)
624,351,021
Net sales (SAR)
460,484,823
Net sales (USD)
122,590,002
Number of employees
731
Sales / Employee (SAR)
629,938
Sales / Employee (USD)
167,702
Free-Float
46.88%
Free-Float capitalization (SAR)
1,099,335,816
Free-Float capitalization (USD)
292,664,541
Average Daily Capital Traded
0.37%
Indicators
Moving average 5 days
66.61
Moving average 20 days
64.48
Moving average 50 days
61.92
Moving average 100 days
60.92
Price spread / (MMA5)
+1.85%
Price spread / (MMA20)
-1.40%
Price spread / (MMA50)
-5.32%
Price spread / (MMA100)
-6.85%
STIM
RSI 9 days
50.06
RSI 14 days
56.07
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.39% | -2.53% | -4.70% | - | 624M | |
| -0.27% | -2.70% | +14.54% | +59.59% | 46.06B | |
| -4.29% | -6.34% | +29.03% | +96.32% | 38.29B | |
| -1.80% | -4.06% | +5.99% | +70.30% | 11.65B | |
| -1.10% | -2.38% | -12.74% | +9.35% | 11.51B | |
| -0.95% | 0.00% | +19.82% | +146.45% | 9.17B | |
| +0.80% | +0.64% | +24.85% | +37.61% | 7.22B | |
| -1.96% | -4.15% | +12.96% | +176.91% | 7.12B | |
| -0.62% | -0.59% | +34.19% | -20.08% | 7.11B | |
| -2.15% | -4.76% | -44.26% | +4.59% | 4.99B | |
| Average | -1.47% | -2.10% | +7.97% | +64.56% | 14.38B | |
| Weighted average by Cap. | -1.70% | -2.67% | +15.14% | +70.67% |
Historical Quotes: Middle East Pharmaceutical Industries Company
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
ebec4c303a81573f9a05d10b78f.-gGFXeggEcApPK3NuGfrt52CUmnFjrOa_DJFwgsmn_o.r0W0EZlXQot4CNqlyiGawMS3DQ-X2uz8y1QkrGJ15pyoNPIai1NXuW5rzg
| Date | Price | Volume | Total |
|---|---|---|---|
| 14:44:15 | 65.20 | 3 | 32,363 |
| 14:44:15 | 65.20 | 50 | 32,360 |
| 14:44:15 | 65.20 | 91 | 32,310 |
| 14:44:15 | 65.20 | 3 | 32,219 |
| 14:41:59 | 65.20 | 9 | 32,216 |
| 14:41:59 | 65.20 | 29 | 32,207 |
| 14:41:59 | 65.20 | 3 | 32,178 |
| 14:41:59 | 65.20 | 1 | 32,175 |
| 14:41:59 | 65.20 | 2 | 32,174 |
| 14:41:59 | 65.20 | 5 | 32,172 |
Price Extremes
| 1 week | 64.8 |  | 67.25 |
| 1 month | 58.6 | | 68.1 |
| Current year | 53.89 | | 68.51 |
| 1 year | 53.89 | | 79.09 |
| 3 years | 51.54 | | 112.91 |
| 5 years | 51.54 | | 112.91 |
| 10 years | 51.54 | | 112.91 |
Monthly variations
Annual variations
| 2026 | +2.92% | ||
| 2025 | -8.70% | ||
| 2024 | +14.26% |
- Stock Market
- Stocks
- 4016 Stock
- Quotes Middle East Pharmaceutical Industries Company
Select your edition
All financial news and data tailored to specific country editions
